Drug profile · INN
cipaglucosidase alfa-atga
POMBILITI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
cipaglucosidase alfa-atga (POMBILITI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN cipaglucosidase alfa-atga
Brand POMBILITI
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is cipaglucosidase alfa-atga?
cipaglucosidase alfa-atga (POMBILITI) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cipaglucosidase alfa-atga?
POMBILITI is a marketed brand name for cipaglucosidase alfa-atga. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cipaglucosidase alfa-atga?
cipaglucosidase alfa-atga has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.